[Home ] [Archive]   [ فارسی ]  
:: Main :: About :: Current Issue :: Archive :: Search :: Submit :: Contact ::
Main Menu
Home::
Journal Information::
Indexing Sources::
Guide for Authors::
Online Submission::
Ethics::
Articles archive::
For Reviewers::
Contact us::
::
Basic and Clinical Biochemistry and Nutrition
..
DOAJ
..
CINAHL
..
EBSCO
..
IMEMR
..
ISC
..
Search in website

Advanced Search
..
Receive site information
Enter your Email in the following box to receive the site news and information.
..
enamad
..
:: Volume 24, Issue 6 (Bimonthly 2020) ::
Feyz Med Sci J 2020, 24(6): 691-703 Back to browse issues page
Cryoprotectants in ovarian vitrification: A review
Atefeh Shirazi-Tehrani , Tahere Mazoochi * , Maryam Akhavan-Taheri
Gametogenesis Research Center, Kashan University of Medical Sciences, Kashan, I.R. Iran. , mazoochi45@yahoo.com
Abstract:   (1605 Views)
Background: The survival of cells after the difficult process of cryopreservation and warming is possible only by using appropriate methods of cryopreservation and the use of appropriate cryoprotective agents (CPAs). This article is a review of some of the research that has been done on cryoprotectants in ovarian vitrification.
Materials and Methods: To conduct this review study, first Pubmed, Scopus, and Embase databases, were researched, with the keywords of cryoprotectant and vitrification. In this study, in addition to introducing some common methods of ovarian cryopreservation, the combination of protective factors against intracellular, extracellular, polymeric, and natural cryopreservation was investigated.
Results: For vitrification of ovarian tissue from intracellular types of CPAs such as ethylene glycol (EG), dimethyl sulfoxide (DMSO), glycerol, propylene glycol, acetamide, and formamide and non-cellular CPAs such as serum proteins, sugar, Polymers are used. Each of these materials has a special efficiency and performance and is generally used in frozen solutions to minimize the damaging effects of the formation of ice crystals both at the intracellular and intra-tissue level.
Conclusion: It seems that more comprehensive research is needed on the best protective compound against cryopreservation so that in addition to maintaining the morphological parameters of the ovary, a variety of functional parameters of this tissue are also preserved after cryopreservation.

 
Keywords: Vitrification of ovary, Warming, Cold protecting, Ice crystals
Full-Text [PDF 1486 kb]   (994 Downloads)    
Type of Study: Review | Subject: General
Received: 2019/07/29 | Revised: 2021/03/1 | Accepted: 2020/10/24 | Published: 2021/02/8
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Shirazi-Tehrani A, Mazoochi T, Akhavan-Taheri M. Cryoprotectants in ovarian vitrification: A review. Feyz Med Sci J 2020; 24 (6) :691-703
URL: http://feyz.kaums.ac.ir/article-1-3944-en.html


Creative Commons License
This open access journal is licensed under a Creative Commons Attribution-NonCommercial ۴.۰ International License. CC BY-NC ۴. Design and publishing by Kashan University of Medical Sciences.
Copyright ۲۰۲۳© Feyz Medical Sciences Journal. All rights reserved.
Volume 24, Issue 6 (Bimonthly 2020) Back to browse issues page
مجله علوم پزشکی فیض Feyz Medical Sciences Journal
Persian site map - English site map - Created in 0.05 seconds with 46 queries by YEKTAWEB 4660